MedPath

A comparative study of 2% lignocaine nebulization with 0.5% ropivacaine nebulization for controlling blood pressure and heart rate during intubation and extubation after general anaesthesia

Recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/09/045630
Lead Sponsor
Goa Medical College and Hospital
Brief Summary

The purpose of this study is to evaluate the effectiveness of local anesthetic nebulization for attenuation of haemodynamic responses during endotracheal intubation and and extubation and to enhance the quality of clinical care during these procedures

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
150
Inclusion Criteria

ASA grade I and II patients.

Exclusion Criteria

1.Patient Refusal 2.Obstetric patients 3.Known allergy to drugs involved in the study 4.Patients with clinical evidence of difficult airway 5.Emergency surgical procedures with full stomach requiring RSI.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of 2% lignocaine with 0.5% ropivacaine 5ml nebulization ,in attenuation of haemodynamic responses during endotracheal intubation and extubationAt Baseline | Before Laryngoscopy and intubation | Immediately after Laryngoscopy and intubation | Every 1 minute for next 5 minutes | 10 minutes after intubation | Upon anaesthetic withdrawal | Upon eye opening on verbal command | Upon tracheal extubation | Two minutes after extubation
Secondary Outcome Measures
NameTimeMethod
To evaluate cough response and haemodynamics during extubation with airway topicalizationseverity of cough and haemodynamic parameters at the time of extubation are studied

Trial Locations

Locations (1)

Goa Medical College and Hospital, Operation Theatre(Lower and Upper OT)

🇮🇳

Goa, GOA, India

Goa Medical College and Hospital, Operation Theatre(Lower and Upper OT)
🇮🇳Goa, GOA, India
Balasai Gorrela
Principal investigator
8885886619
balasaig1@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.